👀 Watchlist Winners: Copy Legendary Investors' Portfolios in One ClickCOPY FOR FREE

Stifel starts Air Canada with hold rating on choppy outlook

EditorTanya Mishra
Published 10/16/2024, 11:48 AM
AC
-

Stifel Canada initiated coverage on Air Canada (AC:CN) (OTC: ACDVF) with a Hold rating and a price target of C$20.00. The firm's analysis suggests that while the airline has made significant strides since the COVID-19 pandemic, it is currently in a phase of rebuilding. The analyst from Stifel Canada believes that Air Canada is approaching a turning point, supported by favorable demographic trends that could strengthen a long-term investment case for the airline.

The decision to start with a Hold rating takes into account the anticipated volatility in the second half of 2024. This forecasted instability is attributed to several factors, including the implications of Air Canada's new pilot contract and potential downward pressures on the company's 2025 financial estimates.

Concerns have been raised regarding the sustainability of leisure travel demand, the normalization of yields and load factors due to increased industry capacity, and rising costs across the board.

Despite these challenges, the analyst acknowledges that Air Canada's valuation, at 3.0 times its projected 2025 EBITDA, already seems to factor in these significant risks. The airline's future performance is expected to become clearer as it reveals its targets for growth, profit margins, and strategies for managing capital expenditures in conjunction with providing returns to shareholders, especially as it updates its narrowbody aircraft fleet.

The Stifel Canada report concludes that should Air Canada effectively communicate its plans and meet its targets, there is potential for the stock to regain momentum and align more closely with the valuations of U.S. airlines.

The analyst's commentary indicates that Air Canada has been working towards reducing the valuation disparity with its American counterparts, a process that was well underway before the pandemic-induced disruption.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.